Novo Nordisk Foundation gives $75m for R&D 'challenges'
The Novo Nordisk Foundation's latest round of R&D funding will go towards projects in biomanufacturing, cardiometabolic diseases, and AI.
pharmaphorum.comHere’s the latest I can share about the Novo Nordisk Foundation (NNF), based on recent public updates.
-
NNF continues its Challenge Programme and has expanded its activities beyond Denmark, with 2025–2026 updates highlighting international collaborations and increased grant activity. The Foundation has underscored its aim to address health, sustainability, and green transformation through large, multi-year grants. [cite ][cite ]
-
In 2024, marking its 100th anniversary, the Foundation awarded a record level of funding, totaling about DKK 10.1 billion (€1.35 billion) to nearly 1,800 projects worldwide, spanning health, sustainability, antimicrobial resistance, and technology initiatives. This milestone reflects continued growth in philanthropic giving and international partnerships. [cite ]
-
The Foundation’s public communications show ongoing funding rounds under the Challenge Programme (and related initiatives) with annual calls for proposals and themed topics that change each year, inviting global participation. The 2026 edition was announced with new themes and expanded geographic reach. [cite ][cite ]
-
Novo Nordisk Foundation maintains a robust online presence with up-to-date press releases and newsroom updates detailing grants, program expansions, and strategic priorities in cardiometabolic and infectious disease areas, as well as supporting green transformation efforts. For the most current specifics, their official site and recent press releases are the best sources. [cite ][cite ]
If you’d like, I can pull the very latest official press releases or summarize the 2026 Challenge Programme details and grant totals from their site. I can also set up a quick-read brief with key numbers and timelines.